Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials

Published:2015-06-11 Issue:6 Volume:10 Page:e0129718
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tang Xiuying,Li Runjun,Jing Quanmin,Liu Yingfeng,Liu Peng

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis;DG Katritsis;Circulation,2005

2. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease;A Schomig;J Am Coll Cardiol,2008

3. The impact of revascularization on mortality in patients with nonacute coronary artery disease;A Jeremias;Am J Med,2009

4. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials;MA Hlatky;Lancet,2009

5. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE);KA Fox;Trial. Circulation,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Tirofiban in Patients with Acute Myocardial Infarction and Diabetes Mellitus undergoing Primary Percutaneous Coronary Intervention;Current Vascular Pharmacology;2024-01

2. Does Adjunctive Prophylactic Intracoronary Infusion of Low Dose Alteplase Prevent No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention?;ARYA ATHEROSCLER;2023

3. Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis;Thrombosis Journal;2023-07-14

4. Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials;Heliyon;2023-05

5. Meta-Analysis of Randomized Controlled Trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention;The Anatolian Journal of Cardiology;2020